ITMI20120027A1 - COSMETIC COMPOSITION WITH REVITALIZING ACTION ON THE EPIDERMIDE - Google Patents
COSMETIC COMPOSITION WITH REVITALIZING ACTION ON THE EPIDERMIDE Download PDFInfo
- Publication number
- ITMI20120027A1 ITMI20120027A1 IT000027A ITMI20120027A ITMI20120027A1 IT MI20120027 A1 ITMI20120027 A1 IT MI20120027A1 IT 000027 A IT000027 A IT 000027A IT MI20120027 A ITMI20120027 A IT MI20120027A IT MI20120027 A1 ITMI20120027 A1 IT MI20120027A1
- Authority
- IT
- Italy
- Prior art keywords
- weight
- composition
- cosmetic composition
- respect
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 46
- 239000002537 cosmetic Substances 0.000 title claims description 17
- 240000002943 Elettaria cardamomum Species 0.000 claims description 7
- 244000014603 Kigelia pinnata Species 0.000 claims description 7
- 235000002329 Kigelia pinnata Nutrition 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 235000018602 Elettaria cardamomum Nutrition 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 229920002674 hyaluronan Polymers 0.000 claims description 6
- 229960003160 hyaluronic acid Drugs 0.000 claims description 6
- 239000011777 magnesium Substances 0.000 claims description 6
- 229910052749 magnesium Inorganic materials 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- 235000014134 echinacea Nutrition 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical class OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims description 3
- 244000133098 Echinacea angustifolia Species 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 244000146462 Centella asiatica Species 0.000 claims description 2
- 235000004032 Centella asiatica Nutrition 0.000 claims description 2
- 240000004530 Echinacea purpurea Species 0.000 claims description 2
- 235000006468 Thea sinensis Nutrition 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 150000002696 manganese Chemical class 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- -1 2-pyrrolidon-5-carboxylic acid manganese Chemical compound 0.000 claims 1
- 241000016446 Erythrococca africana Species 0.000 claims 1
- 241000221095 Simmondsia Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 230000037394 skin elasticity Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000009758 senescence Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- DQAKJEWZWDQURW-UHFFFAOYSA-N pyrrolidonecarboxylic acid Chemical compound OC(=O)N1CCCC1=O DQAKJEWZWDQURW-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- RJZNPROJTJSYLC-LLINQDLYSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O RJZNPROJTJSYLC-LLINQDLYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- PYJQLUORHGLSGS-UHFFFAOYSA-N 16-methylheptadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C PYJQLUORHGLSGS-UHFFFAOYSA-N 0.000 description 1
- DBHODFSFBXJZNY-UHFFFAOYSA-N 2,4-dichlorobenzyl alcohol Chemical compound OCC1=CC=C(Cl)C=C1Cl DBHODFSFBXJZNY-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- XCNILYKGVJTUMZ-UHFFFAOYSA-N 5-oxopyrrolidine-2-carboxylic acid;sodium Chemical compound [Na].OC(=O)C1CCC(=O)N1 XCNILYKGVJTUMZ-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 241000320380 Silybum Species 0.000 description 1
- 235000010841 Silybum marianum Nutrition 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Description
Descrizione dell’invenzione Description of the invention
L’oggetto della presente invenzione è costituito da una composizione cosmetica la quale presenta un’elevata attività idratante ed elasticizzante agendo sulla pelle in maniera favorevole nel ritardarne la senescenza e, nel caso di danni cutanei già instauratisi, nel favorirne il ripristino dell’ elasticità. Detta composizione è costituita da diversi composti, per la maggior parte dei quali è già noto l’utilizzo in campo cosmetico, ma che, nel loro insieme, presentano un favorevole sinergismo di azione che, in particolare, si manifesta in una elevata attività idratante ed elasticizzante della composizione stessa nonché in una sua rimarchevole capacità di penetrazione transcutanea. The object of the present invention consists of a cosmetic composition which has a high moisturizing and elasticizing activity by acting on the skin in a favorable manner in delaying its senescence and, in the case of skin damage that has already established, in helping to restore its elasticity. Said composition consists of various compounds, for the majority of which the use in the cosmetic field is already known, but which, taken together, present a favorable synergism of action which, in particular, manifests itself in a high moisturizing and elasticizing of the composition itself as well as in its remarkable ability of transcutaneous penetration.
I componenti che costituiscono la composizione cosmetica dell’ invenzione sono essenzialmente rappresentati da uno specifico complesso di sostanze minerali, da glicosaminglicani, da piante officinali e loro estratti, siano essi ottenuti mediante processi distillativi o non distillativi, e da vitamine. Sono presenti nella composizione cosmetica dell’invenzione adatti eccipienti compatibili con i componenti succitati e con il tipo di composizione cosmetica richiesta. The components that make up the cosmetic composition of the invention are essentially represented by a specific complex of mineral substances, glycosaminglycans, medicinal plants and their extracts, whether obtained by distillation or non-distillation processes, and vitamins. There are suitable excipients compatible with the aforementioned components and with the type of cosmetic composition required in the cosmetic composition of the invention.
Più specificatamente, i glucosaminglicani sono rappresentati da N-acilesosaminglicani di peso molecolare relativamente basso, generalmente compreso tra 200Da e 800Da, preferibilmente tra 300Da e 500Da. Detti N-acilesosaminglicani sono contenuti nella composizione cosmetica in quantità che può variare da circa lo 0,1 all’8 % in peso rispetto al peso della composizione e fra di essi viene preferibilmente impiegato l’acido ialuronico. More specifically, the glucosaminglycans are represented by N-acylhexaminglycans of relatively low molecular weight, generally between 200Da and 800Da, preferably between 300Da and 500Da. Said N-acylhexaminglycans are contained in the cosmetic composition in quantities that can vary from about 0.1 to 8% by weight with respect to the weight of the composition and hyaluronic acid is preferably used among them.
IL complesso di sostanze minerali è costituito da sali di sodio, di magnesio, di zinco e di manganese dell’acido 2-pirrolidon-5-carbossilico (PCA), sali opportunamente miscelati tra di loro a formare la miscela commercialmente nota con il nome Phisiogenyl. L’acido 2-pirrolidon-5-carbossilico agisce favorevolmente nell’agevolare la penetrazione dell’elemento cui è legato nella cellula epidermica rendendo in tal modo detto elemento utilizzabile dall’organismo. La miscela di sostanze minerali, nella sua totalità, è presente nella composizione cosmetica dell’invenzione in una quantità che può variare tra lo 0,01 % ed il 2,0 %, preferibilmente lo 0,03 %, in peso rispetto al peso della composizione. The complex of mineral substances consists of sodium, magnesium, zinc and manganese salts of 2-pyrrolidon-5-carboxylic acid (PCA), salts suitably mixed together to form the mixture commercially known as Phisiogenyl . The 2-pyrrolidon-5-carboxylic acid acts favorably in facilitating the penetration of the element to which it is bound into the epidermal cell thus making said element usable by the body. The mixture of mineral substances, in its entirety, is present in the cosmetic composition of the invention in an amount that can vary between 0.01% and 2.0%, preferably 0.03%, by weight with respect to the weight of the composition.
Le vitamine presenti nella composizione dell’invenzione sono rappresentate dalla vitamina C, dalla vitamina E, dalla vitamina F e dalla vitamina A, le quali sono, generalmente, presenti nella composizione in una quantità che può variare da circa lo 0,2 al 3,0 % in peso, preferibilmente dallo 0,8 all’ 1,5 % in peso rispetto al peso della composizione. Dette vitamine concorrono ad ostacolare la senescenza cutanea impedendo la formazione dei radicali liberi: esse inoltre combattono la fragilità dei capillari e concorrono a mantenere nella norma i valori dello strato idrolipidico della pelle. The vitamins present in the composition of the invention are represented by vitamin C, vitamin E, vitamin F and vitamin A, which are generally present in the composition in an amount that can vary from about 0.2 to 3, 0% by weight, preferably from 0.8 to 1.5% by weight with respect to the weight of the composition. These vitamins help to hinder skin senescence by preventing the formation of free radicals: they also fight the fragility of the capillaries and help maintain normal values of the hydrolipidic layer of the skin.
Le piante officinali presenti nella composizione cosmetica dell’invenzione sono di natura compatibile con gli altri principi contenuti nella stessa: esse possono essere presenti in forma di olii essenziali o in altra forma adatta. Esempi di dette piante officinali sono, fra le altre, Centella asiatica, Sylibum marianum, Camellia sinensis, Echinacea purpurea ed Echinacea angustifolia, Simmondsia chinensis, Elettaria cardamomum, Kigelia africana. Di particolare interesse sono le composizioni che contengono estratti di entrambe le piante officinali Kigelia africana ed Elettaria cardamomum. La quantità totale di estratto contenuta nella composizione può variare dal 1,0 al 6,5 % in peso, preferibilmente dal 1,3 al 3,5 % in peso rispetto al peso della composizione. The medicinal plants present in the cosmetic composition of the invention are of a nature compatible with the other principles contained therein: they can be present in the form of essential oils or in another suitable form. Examples of said medicinal plants are, among others, Centella asiatica, Sylibum marianum, Camellia sinensis, Echinacea purpurea and Echinacea angustifolia, Simmondsia chinensis, Elettaria cardamomum, Kigelia africana. Of particular interest are the compositions that contain extracts of both the medicinal plants Kigelia africana and Elettaria cardamomum. The total amount of extract contained in the composition can vary from 1.0 to 6.5% by weight, preferably from 1.3 to 3.5% by weight with respect to the weight of the composition.
La composizione cosmetica dell’invenzione è adatta ad essere formulata, unitamente ad opportuni eccipienti, come emulsione cremosa, emulsione fluida, unguento, gel, crema o soluzione. Quali adatti eccipienti, dipendentemente dal tipo di forma prescelta, possono essere usati, ad esempio, cera d’api, olio di jojoba, isostearil stearato, gliceril stearato, acidi grassi, trigliceridi, glicole propilenico, idrossipropil-metilcellulosa. Possono inoltre essere incluse nelle suddette formulazioni sostanze conservanti e/o antiossidanti e/o stabilizzanti. Quali conservanti possono essere usati, ad esempio, metilparaben, etilparaben, esteri dell’acido p-idrossibenzoico, acido lattico, imidazolidinilurea. Quali antiossidanti possono essere usati, ad esempio, butilidrossianisolo (BHA), di-terz.butil-p.cresolo (BHT), acido citrico, sodio tiosolfato. The cosmetic composition of the invention is suitable for being formulated, together with suitable excipients, such as creamy emulsion, fluid emulsion, ointment, gel, cream or solution. As suitable excipients, depending on the type of form chosen, can be used, for example, beeswax, jojoba oil, isostearyl stearate, glyceryl stearate, fatty acids, triglycerides, propylene glycol, hydroxypropyl-methylcellulose. Furthermore, preservatives and / or antioxidants and / or stabilizers can be included in the above formulations. Which preservatives can be used, for example, methylparaben, ethylparaben, esters of p-hydroxybenzoic acid, lactic acid, imidazolidinylurea. As antioxidants, for example, butylhydroxyanisole (BHA), di-tert-butyl-p.cresol (BHT), citric acid, sodium thiosulfate can be used.
La composizione cosmetica oggetto dell’invenzione trova applicazione particolarmente nelle forme di senescenza cutanea, quando cioè per L invecchiamento o per un insieme di fattori ambientali, la pelle subisce una serie di processi involutivi che ne determinano, come conseguenza, la perdita di elasticità, disidratazione, secchezza e la conseguente comparsa di rughe. The cosmetic composition object of the invention finds application particularly in the forms of skin senescence, i.e. when due to aging or a set of environmental factors, the skin undergoes a series of involutional processes which determine, as a consequence, the loss of elasticity, dehydration , dryness and the consequent appearance of wrinkles.
Un trattamento consigliato per ottenere risultati di rilievo richiede l’applicazione, due-tre volte al giorno, di un sottile strato della composizione cosmetica dell’invenzione sulla pelle da trattare. L’attività dei singoli componenti costituenti la composizione cosmetica dell’invenzione si manifesta, in detta composizione, in maniera decisamente potenziata. Vengono fomiti di seguito alcuni esempi di formulazioni della presente composizione cosmetica che non devono comunque essere considerati limitanti l’ambito dell’invenzione. A recommended treatment to obtain significant results requires the application, two or three times a day, of a thin layer of the cosmetic composition of the invention on the skin to be treated. The activity of the individual components making up the cosmetic composition of the invention is manifested, in said composition, in a decidedly enhanced manner. Some examples of formulations of this cosmetic composition are provided below which should not in any case be considered limiting the scope of the invention.
Esempio 1 Example 1
Composizione di una crema urto anti-age: Composition of an anti-aging shock cream:
Physiogenyl (sali di Na, Mg, Zn e Mn dell’acido 2-pirrolidoncarbossilico) 0,30 g Squalano-vitabiosol S 55,00 g Kigelia africana e.g. 10,00 g Elettaria cardamomum o.e. 3,00 g Sale di lisina dell’acido ialuronico 3,00 g Akest TCC 40,00 g Pantenolo 50P 40,00 g Glicerina vegetale USP 99,5% 23,00 g Alcool cetil stearilico 21,00 g Argireline 20,00 g Sorbirai S 13,00 g Sorbilene S-mulsifan T 60 13,00 g Pseudo collagene 10,00 g Olio di jojoba 10,00 g Fluilan 10,00 g Trietanolamina 90% 5,00 g Polygel CA 5,00 g PMP 5,00 g Vitamina E acetato 3,00 g Compound 38118 Angel x crema 2,00 g Dimetilpolisilossano 350 2,00 g Alfa bisabololo 1,50 g Propoli atomizzato 1,00 g Prevan B 1 ,00 g Myacide SP 1,00 g Vitamina A palmitato 0,50 g Aperoxide TLA 0,30 g Allantoina 0,30 g Acqua demineralizzata q.s. a 1.000,00 g Esempio 2 Physiogenyl (salts of Na, Mg, Zn and Mn of 2-pyrrolidone carboxylic acid) 0.30 g Squalane-vitabiosol S 55.00 g Kigelia africana e.g. 10.00 g Elettaria cardamomum o.e. 3.00 g Lysine salt of hyaluronic acid 3.00 g Akest TCC 40.00 g Panthenol 50P 40.00 g Vegetable glycerin USP 99.5% 23.00 g Cetyl stearyl alcohol 21.00 g Argireline 20.00 g Sorbirai S 13.00 g Sorbylene S-mulsifan T 60 13.00 g Pseudo collagen 10.00 g Jojoba oil 10.00 g Fluilan 10.00 g Triethanolamine 90% 5.00 g Polygel CA 5.00 g PMP 5, 00 g Vitamin E acetate 3.00 g Compound 38118 Angel x cream 2.00 g Dimethylpolysiloxane 350 2.00 g Alpha bisabolol 1.50 g Atomized propolis 1.00 g Prevan B 1, 00 g Myacide SP 1.00 g Vitamin A palmitate 0.50 g Aperoxide TLA 0.30 g Allantoin 0.30 g Demineralized water q.s. at 1,000.00 g Example 2
Composizione di una crema Thermal Body Composition of a Thermal Body cream
Physiogenyl (sali di Na, Mg, Zn e Mn dell’acido 2-pirrolidoncarbossilico) 0,30 g Squalano-vitabiosol S 55,00 g Kigelia africana e.g. 10,00 g Elettaria cardamomum o.e. 3,00 g Sale di lisina dell’acido ialuronico 3,00 g Fluido 190 100,00 g Issy soluzione idro 50,00 g Burro di karité idrosolubile 7,00 g Polymer JR 30 M 7,00 g Physiogenyl (salts of Na, Mg, Zn and Mn of 2-pyrrolidone carboxylic acid) 0.30 g Squalane-vitabiosol S 55.00 g Kigelia africana e.g. 10.00 g Elettaria cardamomum o.e. 3.00 g Lysine salt of hyaluronic acid 3.00 g Fluid 190 100.00 g Issy hydro solution 50.00 g Water-soluble shea butter 7.00 g Polymer JR 30 M 7.00 g
Té verde e.g. 5,00 g Green tea e.g. 5.00 g
Cardo mariano e.g. 5,00 g Milk thistle e.g. 5.00 g
Echinacea e.g. 5,00 g Echinacea e.g. 5.00 g
Crodacel QM 5,00 g Crodacel QM 5.00 g
Abiol 3,00 g Abiol 3.00 g
Vitamina F idro nuova 2,00 g Vitamin F hydro new 2.00 g
Vitamina A solubilizzata 2,00 g Solubilized Vitamin A 2.00 g
Vitamina E idrosolubile 2,00 g Water-soluble Vitamin E 2.00 g
Orange 50 BRIX 2,00 g Orange 50 BRIX 2.00 g
Uva sorb S/5 0,50 g Grape sorb S / 5 0.50 g
Acqua demineralizzata q.s. 1.000,00 g Demineralized water q.s. 1,000.00 g
Esempio 3 Example 3
Formulazione di un’emulsione Formulation of an emulsion
A 20 g di una fase oleosa, contenente adatti olii vegetali, cere, trigliceridi sintetici, esteri, siliconi ed alcoli di acidi grassi, vengono aggiunti, alla temperatura di 70-75°C, 8 g di sostanze emulsionanti, quali, ad esempio, alcooli o acidi grassi etossilati, esteri etossilati del sorbitano, quindi alla miscela formatasi si aggiunge, in un omogeneizzatore, sotto agitazione, una fase acquosa, costituita da una miscela in acqua demineralizzata di sostanze umettanti, sostanze gelificanti e conservanti, preriscaldata a 70°C. La miscela viene omogeneizzata per 10-15 minuti, si raffredda a 30-35°C mantenendo l’emulsione sotto agitazione e si aggiungono 2 g di olio essenziale di Cardamomo, 8 g di estratto glicolico di Kigelia africana, 15 g della miscela di sali di sodio, zinco, magnesio e manganese dell’acido 2-pirrolidon-5-carbossilico, 3 g del sale di lisina dell’acido ialuronico e 6 g di una miscela di vitamine A, C ed E. To 20 g of an oily phase, containing suitable vegetable oils, waxes, synthetic triglycerides, esters, silicones and alcohols of fatty acids, 8 g of emulsifying substances are added at a temperature of 70-75 ° C, such as, for example, ethoxylated alcohols or fatty acids, ethoxylated esters of sorbitan, then to the mixture formed an aqueous phase is added, in a homogenizer, under stirring, consisting of a mixture in demineralized water of humectants, gelling substances and preservatives, preheated to 70 ° C . The mixture is homogenized for 10-15 minutes, it is cooled to 30-35 ° C while keeping the emulsion under stirring and 2 g of Cardamom essential oil, 8 g of Kigelia africana glycolic extract, 15 g of the mixture of salts are added. 2-pyrrolidon-5-carboxylic acid sodium, zinc, magnesium and manganese, 3 g of hyaluronic acid lysine salt and 6 g of a mixture of vitamins A, C and E.
Si omogenizza per circa 2 minuti e si raffredda a temperatura ambiente ottenendo l’emulsione desiderata pronta all’uso. It is homogenized for about 2 minutes and cooled to room temperature, obtaining the desired emulsion ready for use.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000027A ITMI20120027A1 (en) | 2012-01-12 | 2012-01-12 | COSMETIC COMPOSITION WITH REVITALIZING ACTION ON THE EPIDERMIDE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000027A ITMI20120027A1 (en) | 2012-01-12 | 2012-01-12 | COSMETIC COMPOSITION WITH REVITALIZING ACTION ON THE EPIDERMIDE |
Publications (1)
Publication Number | Publication Date |
---|---|
ITMI20120027A1 true ITMI20120027A1 (en) | 2013-07-13 |
Family
ID=45814578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT000027A ITMI20120027A1 (en) | 2012-01-12 | 2012-01-12 | COSMETIC COMPOSITION WITH REVITALIZING ACTION ON THE EPIDERMIDE |
Country Status (1)
Country | Link |
---|---|
IT (1) | ITMI20120027A1 (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5391373A (en) * | 1992-07-01 | 1995-02-21 | Chanel, Inc. | Skin cream composition |
FR2789901A1 (en) * | 1999-02-22 | 2000-08-25 | Clarins | Cosmetic preparation for skin care contains extract of sunflower stalks and/or extract of sequoia branches to provide the vegetable hormone auxin as active agent |
EP1407759A1 (en) * | 2002-10-11 | 2004-04-14 | Giuseppe Petrigni | A cosmetic composition in colloidal form comprising hyaluronic acids and chitosan |
WO2006002443A1 (en) * | 2004-06-24 | 2006-01-05 | Rudolf Karl Schleipfer | Pharmaceutical or cosmetic preparation based on kigelia africana |
US20060257509A1 (en) * | 2003-10-10 | 2006-11-16 | Zimmerman Amy C | Cosmetic composition and methods |
US20070243155A1 (en) * | 2006-04-18 | 2007-10-18 | Pierre Bottiglieri | Skin care method and products |
WO2008079898A1 (en) * | 2006-12-20 | 2008-07-03 | Pharmwest, Inc. | Methods and topical formulations comprising colloidal metal for treating or preventing skin conditions |
FR2926725A1 (en) * | 2008-01-25 | 2009-07-31 | Biochimie Appliquee Sa Soc | Cosmetic and/or dermatological composition, useful for promoting skin healing, comprises polyunsaturated fatty acid compound as an active ingredient, in combination with an excipient and/or a carrier for topical application |
US20100298259A1 (en) * | 2007-05-11 | 2010-11-25 | Marc Moutet | Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same |
WO2011103449A2 (en) * | 2010-02-19 | 2011-08-25 | Mary Kay Inc. | Topical skin care formulation |
-
2012
- 2012-01-12 IT IT000027A patent/ITMI20120027A1/en unknown
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5391373A (en) * | 1992-07-01 | 1995-02-21 | Chanel, Inc. | Skin cream composition |
FR2789901A1 (en) * | 1999-02-22 | 2000-08-25 | Clarins | Cosmetic preparation for skin care contains extract of sunflower stalks and/or extract of sequoia branches to provide the vegetable hormone auxin as active agent |
EP1407759A1 (en) * | 2002-10-11 | 2004-04-14 | Giuseppe Petrigni | A cosmetic composition in colloidal form comprising hyaluronic acids and chitosan |
US20060257509A1 (en) * | 2003-10-10 | 2006-11-16 | Zimmerman Amy C | Cosmetic composition and methods |
WO2006002443A1 (en) * | 2004-06-24 | 2006-01-05 | Rudolf Karl Schleipfer | Pharmaceutical or cosmetic preparation based on kigelia africana |
US20070243155A1 (en) * | 2006-04-18 | 2007-10-18 | Pierre Bottiglieri | Skin care method and products |
WO2008079898A1 (en) * | 2006-12-20 | 2008-07-03 | Pharmwest, Inc. | Methods and topical formulations comprising colloidal metal for treating or preventing skin conditions |
US20100298259A1 (en) * | 2007-05-11 | 2010-11-25 | Marc Moutet | Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same |
FR2926725A1 (en) * | 2008-01-25 | 2009-07-31 | Biochimie Appliquee Sa Soc | Cosmetic and/or dermatological composition, useful for promoting skin healing, comprises polyunsaturated fatty acid compound as an active ingredient, in combination with an excipient and/or a carrier for topical application |
WO2011103449A2 (en) * | 2010-02-19 | 2011-08-25 | Mary Kay Inc. | Topical skin care formulation |
Non-Patent Citations (1)
Title |
---|
"A c t i v e i n g r e d i e n t s", 27 August 2010 (2010-08-27), pages 1 - 10, XP055038817, Retrieved from the Internet <URL:http://web.archive.org/web/20100827083129/http://www.solabia.fr/solabia/content/NT00005516.pdf> [retrieved on 20120921] * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080014153A1 (en) | Topical Preparation For Application To The Skin Containing Natural Oil Of The Evening Primrose (Oenothera Biennis) (=Oleum Oenotherae) And Osmolytes Originating From Extremophilic Microorganisms | |
US20140271596A1 (en) | Emulsified hydrogel composition and a production method therefor | |
KR101262557B1 (en) | Natural korean herb cosmetic | |
KR20140011550A (en) | Oil capsule composition for an cosmetic | |
KR101909980B1 (en) | Cosmetic composition containing moisturizing complex | |
KR20180119550A (en) | Cosmetic Composition for skin moisturizing comprising Aquilaria agallocha Roxburgh extracts | |
CN103356465A (en) | Grape seed powder anti-oxidant face mask | |
KR101317430B1 (en) | The cosmetic composition for moisturizing comprising the mixture of extract of flower of Rhododendron mucronulatum var. lucidum Nakai , Malus pumila var. dulcissima and Magnolia sieboldii | |
KR101312965B1 (en) | The cosmetic composition for anti-wrinkle comprising the mixture of extract of Allium cepa, Symphytum officinale, Eclipta prostrate, and Theobroma cacao | |
KR20110068049A (en) | Cosmetic composition containing cyperus papyrus extracts and pueraria radix extracts for moisturing effect on the skin | |
JP2018527401A5 (en) | ||
KR101460777B1 (en) | Cosmetic composition for improving acne | |
ES2377226T3 (en) | Combinations of active ingredients based on an anise fruit extract and a white tea extract | |
KR20110052095A (en) | Cosmetic composition for moisturizing of skin containing tremella fuciformis extracts | |
ES2541379B1 (en) | Acorn natural cosmetics | |
KR100858628B1 (en) | Cosmetic Composition for alleviating Skin Irritation Comprising Rumex Crispus L. Extract Stabilized in Nanoliposome | |
ITMI20120027A1 (en) | COSMETIC COMPOSITION WITH REVITALIZING ACTION ON THE EPIDERMIDE | |
ITMI20072063A1 (en) | MULTIFUNCTIONAL COSMETIC COMPOSITIONS FOR THE CARE AND THE WELL-BEING OF THE SKIN | |
KR100667182B1 (en) | Cosmetics for improvement xeroderma containing badger oil | |
CN103751214A (en) | Alligator oil nano-liposome and preparation method thereof | |
CA2867340A1 (en) | Cosmetic composition | |
KR20180069530A (en) | Cosmetic Composition for skin moisturizing comprising Aquilaria agallocha Roxburgh extracts | |
KR101541686B1 (en) | Cosmetic composition | |
KR101228967B1 (en) | Cosmetic composition containing pear and method of the same | |
DE102006040450B3 (en) | Use of a composition for skin treatment after X-irradiation |